slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 61,891-61,920
Pages 2,605
Rows per page 30
Component
61,891-61,920 of 78,138
38
The slide uses a process flow to connect market size to proprietary methodology and specific pipeline assets.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
43
The chart shows a scatter plot with a regression line indicating a correlation coefficient (rho) of 0.86.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
44
Data shows 23ME '610 consistently outperforms isotype control and anti-PD1 in IFNy production across most tested cancer types.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
56
Uses a linguistic analogy to explain genetic imputation.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
19
Uses a timeline comparison to illustrate value proposition.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
20
The chart uses a dot-plot visualization to represent cash flow magnitude over time, categorized by development stages.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
26
The slide uses a growth curve (exponential) to visualize progress over time.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
04
The slide uses a Gantt-style chart to represent clinical trial progress.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
11
The chart displays efficacy data for a drug candidate, noting the impact of anti-drug antibodies (ADAs) on the third cohort.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
19
The slide uses a heatmap to visualize individual patient outcomes, highlighting clinical improvement vs. worsening.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
25
Includes a Kaplan-Meier survival curve and a comparative table of clinical outcomes.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
26
The chart shows a clear dose-response relationship where the 10.0 mg/kg dose achieves a more significant and sustained reduction in tHcy compared to the 1.0 mg/kg dose.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
28
Includes histological images of liver tissue and a dot plot for bone mineral density (BMD).Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
31
Box plot visualization of clinical trial results.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
09
The chart illustrates the revenue contribution of four products: VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
10
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
11
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
12
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
13
The chart includes a vertical dashed line separating 2021 from 2022.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
05
The chart includes a callout bubble highlighting the growth rate.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
06
The chart shows a decline in operating income over the trailing twelve-month periods.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
07
The chart illustrates financial performance over five quarters, with a specific footnote explaining the impact of Rivian Automotive investment valuation changes.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
08
The slide includes a footnote explaining the impact of Rivian Automotive investment valuation changes on the net income figures.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
12
The chart shows negative cash flow values improving over time.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Long-Term GoalLoop · Cost Of Inaction1 hit
13
The chart displays negative values (outflows) narrowing over time, indicating improved cash flow performance.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Long-Term GoalLoop · Cost Of Inaction1 hit
14
The chart displays negative values (cash outflows/investments) narrowing over time.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Long-Term GoalLoop · Cost Of Inaction1 hit
15
The chart highlights the stability of share counts over time, supporting the goal of managing dilution.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
07
The slide uses a waterfall-style bar chart to show quarterly revenue growth throughout the year.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
21
The chart uses color-coding to represent therapeutic areas: Neurology (light green), Hematology and Rheumatology (light blue), Dermatology (dark blue), and Nephrology (dark green).argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
11
The slide uses a pie chart to visualize the distribution of 214 total patents granted or pending as of 12/31/2022.Arrival | SPAC Presentation Deck | 21 slides · Arrival
Pitch deck Investment bank 1 hit